RXRX - Dinamika pendapatan YoY sajrone rolas wulan kepungkur Recursion Pharmaceuticals

The 12-month revenue trajectory illustrates the dynamics of Recursion Pharmaceuticals (RXRX), where 56.10 shows the current value of the metric. Business development depends on access to powerful chips and geopolitical stability. The company's success is based on laboratory achievements and partnerships, ignoring economic cycles. The integration of AI into medicine ensures long-term growth and financial stability.

RXRX Recursion Pharmaceuticals, Inc.: Wutah dodolan YoY sajrone rolas wulan kepungkur ing interval 11.02.2024 - 15.11.2026

recursion.com (RXRX) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:

Bagan kutipan Recursion Corp|RXRX - Prakiraan konsensus analis

- statistik kapitalisasi pasar:

Nilai pasar Recursion Pharmaceuticals, Inc.|RXRX - Nilai Perusahaan

- informasi kapitalisasi buku:

Nilai Buku saben Saham Recursion|RXRX - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku recursion.com|RXRX - Aset Agregat Perusahaan

- rincian struktur utang lan likuiditas bisnis:

- data bathi bisnis lan rasio investasi:

RXRX - Penghasilan resik|Bathi resik mangsa ngarep Recursion Pharmaceuticals|RXRX - Pangali P/E|Kapitalisasi marang proyeksi bathi Recursion Pharma|RXRX - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Recursion Pharmaceuticals, Inc.|RXRX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Recursion|RXRX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan recursion.com|RXRX - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Recursion Pharmaceuticals

- data dodolan lan asil:

RXRX - Pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan Recursion Pharmaceuticals, Inc.|RXRX - Kapitalisasi marang pendapatan|Kapitalisasi marang prakiraan pendapatan Recursion Pharmaceuticals Inc|RXRX - Wutah dodolan YoY sajrone rolas wulan kepungkur

Ringkesan analitik perusahaan:RXRX - Recursion Pharmaceuticals Inc

This indicator captures the percentage change in revenue over the last 12 months, neutralizing time gaps between quarterly reports. Investors utilize this calculation for a real-time assessment of business scaling rates. By analyzing year-over-year revenue changes over the TTM 12-month period, one can determine the monetization efficiency of the AI platform. For Recursion Pharmaceuticals (RXRX), growth in this metric confirms the commercial success of laboratory automation and digital data processing.

Karo sapa Recursion Pharmaceuticals saingan